Not exact matches
Before I go any further, though, a series of hat tips to Richard Nikoley, Tatertot Tim, and Dr. BG, whose
early and ongoing research
into the benefits, real - world implications, and
clinical applications of resistant starch have proved to be a real asset for the ancestral health community.
This is an incredibly difficult question to answer for a variety of reasons, most importantly because over the years our once vaunted «beautiful» style of play has become a shadow of it's former self, only to be replaced by a less than stellar «plug and play» mentality where players play out of position and adjustments / substitutions are rarely forthcoming before the 75th minute... if you look at our current players, very few would make sense in the traditional Wengerian system... at present, we don't have the personnel to move the ball quickly from deep - lying position, efficient one touch midfielders that can make the necessary through balls or the disciplined and pacey forwards to stretch defences
into wide positions, without the aid of the backs coming up
into the final 3rd, so that we can attack the defensive lanes in the same
clinical fashion we did years ago... on this current squad, we have only 1 central defender on staf, Mustafi, who seems to have any prowess in the offensive zone or who can even pass two zones through so that we can advance play quickly out of our own end (I have seen some inklings that suggest Holding might have some offensive qualities but too
early to tell)... unfortunately Mustafi has a tendency to get himself in trouble when he gets overly aggressive on the ball... from our backs out wide, we've seen pace from the likes of Bellerin and Gibbs and the spirited albeit offensively stunted play of Monreal, but none of these players possess the skill - set required in the offensive zone for the new Wenger scheme which requires deft touches, timely runs to the baseline and consistent crossing, especially when Giroud was playing and his ratio of scored goals per clear chances was relatively low (better last year though)... obviously I like Bellerin's future prospects, as you can't teach pace, but I do worry that he regressed last season, which was obvious to Wenger because there was no way he would have used Ox as the right side wing - back so often knowing that Barcelona could come calling in the off - season, if he thought otherwise... as for our midfielders, not a single one, minus the more confident Xhaka I watched played for the Swiss national team a couple years ago, who truly makes sense under the traditional Wenger model... Ramsey holds onto the ball too long, gives the ball away cheaply far too often and abandons his defensive responsibilities on a regular basis (doesn't score enough recently to justify): that being said, I've always thought he does possess a little something special, unfortunately he thinks so too... Xhaka is a little too slow to ever boss the midfield and he tends to telegraph his one true strength, his long ball play: although I must admit he did get a bit better during some points in the latter part of last season... it always made me wonder why whenever he played with Coq Wenger always seemed to play Francis in a more advanced role on the pitch... as for Coq, he is way too reckless at the wrong times and has exhibited little offensive prowess yet finds himself in and around the box far too often... let's face it Wenger was ready to throw him in the trash heap when injuries forced him to use Francis and then he had the nerve to act like this was all part of a bigger Wenger constructed plan... he like Ramsey, Xhaka and Elneny don't offer the skills necessary to satisfy the quick transitory nature of our old offensive scheme or the stout defensive mindset needed to protect the defensive zone so that our offensive players can remain aggressive in the final third... on the front end, we have Ozil, a player of immense skill but stunted by his physical demeanor that tends to offend, the fact that he's been played out of position far too many times since arriving and that the players in front of him, minus Sanchez, make little to no sense considering what he has to offer (especially Giroud); just think about the quick counter-attack offence in Real or the space and protection he receives in the German National team's midfield, where teams couldn't afford to focus too heavily on one individual... this player was a passing «specialist» long before he arrived in North London, so only an arrogant or ignorant individual would try to reinvent the wheel and / or not surround such a talent with the necessary components... in regards to Ox, Walcott and Welbeck, although they all possess serious talents I see them in large part as headless chickens who are on the injury table too much, lack the necessary first - touch and / or lack the finishing flair to warrant their inclusion in a regular starting eleven; I would say that, of the 3, Ox showed the most upside once we went to a back 3, but even he became a bit too consumed by his pending contract talks before the season ended and that concerned me a bit... if I had to choose one of those 3 players to stay on it would be Ox due to his potential as a plausible alternative to Bellerin in that wing - back position should we continue to use that formation... in Sanchez, we get one of the most committed skill players we've seen on this squad for some years but that could all change soon, if it hasn't already of course... strangely enough, even he doesn't make sense given the constructs of the original Wenger offensive model because he holds onto the ball too long and he will give the ball up a little too often in the offensive zone... a fact that is largely forgotten due to his infectious energy and the fact that the numbers he has achieved seem to justify the means... finally, and in many ways most crucially, Giroud, there is nothing about this team or the offensive system that Wenger has traditionally employed that would even suggest such a player would make sense as a starter... too slow, too inefficient and way too easily dispossessed... once again, I think he has some special skills and, at times, has showed some world - class qualities but he's lack of mobility is an albatross around the necks of our offence... so when you ask who would be our best starting 11, I don't have a clue because of the 5 or 6 players that truly deserve a place in this side, 1 just arrived, 3 aren't under contract beyond 2018 and the other was just sold to Juve... man, this is theraputic because following this team is like an addiction to heroin without the benefits
ACT is now performing
early - phase
clinical trials testing the safety of implanting retinal cells derived from human ES cells
into the eye to treat certain types of blindness.
«It's become clear that many of the other cannabinoids have potential therapeutic activity, but it's still too
early to tell whether that's going to translate
into clinical trial data or not,» said Mark Ware from McGill University Health Centre in Montreal, Canada.
Developing the idea
into presentable form while working together across departments, on top of the regular workload, is an important
early achievement, says Anil Dutta, vice president,
clinical R&D and medical affairs, GSK Biologicals.
So now, with late - stage
clinical failures piling up, the U.S. Food and Drug Administration (FDA) has set off down a path to adapt those standards as researchers are pushed inexorably
into earlier and
earlier forms of the disease, ahead of the brain damage inflicted by Alzheimer's.
The lead researcher for the study, Professor Gita Mishra, Professor of Life Course Epidemiology and Director of the Australian Longitudinal Study on Women's Health at the University of Queensland, Australia, said: «If the findings from our study were incorporated
into clinical guidelines for advising childless women from around the age of 35 years who had their first period aged 11 or younger, clinicians could gain valuable time to prepare these women for the possibility of premature or
early menopause.
The study divides 177 blood and 27 post-mortem brain samples
into several groups, establishing that careful analysis of RNA transcripts in blood samples has the ability to distinguish
early clinical AD, Parkinson's disease (PD), and cognitively healthy patients.
In addition to providing new insights
into how genes and the environment interact, the results may have
early implications for
clinical management of CD.
«The next step is to figure out how to bring this finding
into early - phase
clinical trials with patients, and we're partnering with pharmaceutical companies to explore this,» Goga said.
«Our collective research has shown that horses can often develop this disease
earlier in life, yet
earlier clinical signs don't always translate into positive test results,» said Nicholas Frank, D.V.M, DACVIM, professor and chair of the Department of Clinical Sciences at the Cummings School of Veterinary Medicine at Tufts University and group coordinator for the Equine Endocrinolog
clinical signs don't always translate
into positive test results,» said Nicholas Frank, D.V.M, DACVIM, professor and chair of the Department of
Clinical Sciences at the Cummings School of Veterinary Medicine at Tufts University and group coordinator for the Equine Endocrinolog
Clinical Sciences at the Cummings School of Veterinary Medicine at Tufts University and group coordinator for the Equine Endocrinology Group.
These
early results could be translated
into a treatment relatively quickly, says Jesus Gil of the MRC
Clinical Sciences Centre (CSC), based at Imperial College London, and who led the study.
«Eventually we hope to introduce brain health index
into clinical practice so that it may improve
early identification and treatment of cognitive decline and dementia after stroke.»
While it is too
early to identify all of the potential ELSI issues that may emerge in this field, such considerations should be factored
into the development of policy recommendations for public health and
clinical practice in infectious disease, both domestically and internationally [106].
Together with the research and
clinical resources of the nation's leading cancer hospital, we have the ability to take a program from a research hypothesis all the way to a
clinical candidate supported by robust preclinical data, and
into early phase
clinical studies in well - defined patient populations.
There are now multiple immunotherapies targeting clearance of alpha - synuclein from the brain in
early - stage
clinical trials, and multiple trials underway or in the works on the next generation of cell replacement therapies for dopaminergic neurons, including the TRANSEURO trial; the Summit4StemCell initiative, put together by Jeanne Loring — a researcher at The Scripps Research Institute who is exceptionally engaged with turning her research
into therapies; a Japanese trial to be run by Jun Takahashi of Kyoto University in Japan (cf. here and here); and a trial centered at Memorial Sloan Kettering Cancer Center headed by cell biologist Lorenz Studer.
EVI's main focus remains on the discovery of antigens for diseases of poverty and their introduction
into early stages of
clinical development.
City of Hope patients have access to a wide variety of
clinical trials looking
into early - detection for lung cancer, the newest chemotherapy treatments, targeted therapies and surgical and radiation approaches — all with the goal of helping extend life.
The scientific goal of the Developmental Cancer Therapeutics Program is to discover and characterize unique agents and pathways that will impact the development of more effective cancer therapies and to translate these discoveries
into clinical applications by using proof - of - principle,
early phase
clinical and correlative science studies.
The drug is ready to be taken
into early phase
clinical trials.
It will be produced at Waisman Biomanufacturing, a specialized facility whose mission is to help translate scientific discovery
into early - stage
clinical trials.
Despite ongoing efforts toward finding novel entities for the treatment of the most challenging cancers, translation
into patient benefit has been slow due to the fact that translational cancer research from
early drug discovery to late stage drug development and assessment in
clinical trials is a long process.
«This is the first objective, physiological marker for two major psychiatric disorders that, once fully developed
into a
clinical test, can allow for
earlier and more accurate diagnosis, and selection of more appropriate medications for patients.»
In this two - part series, I hope to provide some insight
into how you can beat the heat and (hopefully) your competition starting with heat acclimatization education and strategies (part I) followed by proper hydration and cooling methods and how to recognize
early signs of heat exhaustion, a potentially dangerous
clinical scenario (part II).
Unlike series co-star Biel, Mitchell remained with the program throughout its run, and through many character changes that found Lucy marrying Kevin Kinkirk, working as an associate pastor, giving birth, and surviving both a miscarriage to twins and
clinical depression.Although Mitchell branched out from television
into cinematic work as
early as 1996, with a turn in the fantasy - action thriller The Crow: City of Angels, and continued intermittent film appearances (such as a supporting role in 2005's slasher movie Saw II), she made no secret of her real passion: performing country music as a guitarist and vocalist.
In recognition of the need for more and especially better
clinical preparation, researchers are now arguing for a shift away from the typical student teaching experience as a distinct and final step in completing preparation and toward integrating
clinical components
into the preparation experience
early and throughout the program.30 A number of programs across the country have made this shift, including by incorporating residency models
into their teacher preparation programs, 31 but this kind of program design is still relatively uncommon.
Clinical Findings and Lesions:
Early lesions of interdigital furunculosis may appear as focal or generalized areas of erythema and papules in the webbing of the feet that, if left untreated, rapidly develop
into single or multiple nodules.
Intervention effects on diurnal cortisol rhythms of CPS - referred infants persist
into early childhood: Preschool follow - up results of a randomized
clinical trial.
These programs include the Cuna Mas Home Visiting programme in Peru, and a program supported by PATH in Mozambique to integrate
early childhood development screening and counselling
into the routine work of community health workers and
clinical providers.